The UK Government has launched a joint public-private investment programme worth up to £400 million, hoping to help NHS patients have earlier access to new treatments and ensure the UK becomes the home of cutting-edge health research. The Voluntary Scheme for Branded Medicine Pricing, Access, and Growth (VPAG) Investment Programme opens today. It aims to channel significant investment into the…
Ben KempAugust 28, 2024